Brought to you by 
Amersham Biosciences, Aurora market GFP technology
27 Feb 2002
Executive Summary
Amersham Biosciences (life science business of Amersham PLC) and Vertex Pharmaceuticals' Aurora Biosciences (fluorescence assay and screening company) will market green fluorescent protein (GFP) technology to accelerate the drug discovery and development process.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Amersham Biosciences, Aurora market GFP technology
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice